Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects

Abstract

Objective:

In vitro measurements of cholesterol efflux from macrophages have recently been shown to associate with cardiovascular risk. We investigated whether cholesterol efflux from macrophages incubated with plasmas from overweight/obese subjects with metabolic syndrome was influenced by the presence of insulin resistance.

Methods:

Plasmas were obtained from 47 men and women with metabolic syndrome, of whom 25 were found to be insulin resistant (IR) and 22 insulin sensitive (IS) (Matsuda, De Fronzo equation based on oral glucose tolerance test). Activated human macrophage THP-1 cells in which cholesterol had been radiolabelled were incubated with the subjects’ plasmas to allow calculation of % cholesterol efflux.

Results:

Body mass index and waist measurements, as well as plasma lipid levels, did not differ between the two groups. Homeostatic model assessment-insulin resistance value as well as plasma insulin and leptin concentrations were higher in IR subjects. Cholesterol efflux was found to be significantly greater with plasmas from IR subjects (9.1%) than from IS subjects (6.7%) (P=0.005). Further, cholesterol efflux was significantly inversely associated with insulin sensitivity index (P<0.001), directly with arterial insulin concentration (P<0.001) and directly with cholesteryl ester transfer protein (CETP) mass (P=0.044).

Conclusion:

Plasmas from overweight subjects with insulin resistance induced greater in vitro cholesterol efflux compared with IS subjects. Efflux inversely correlated with insulin sensitivity suggesting an increase in reverse cholesterol transport in the IR state that may lead to greater transfer of cholesterol to apoB lipoproteins from high-density lipoproteins via CETP as a factor in the association between IR and atherosclerosis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Khera AV, Cuchel M, de la Llera-Moya M, Rodriguez A, Burke MF, Jafri K et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. New Engl J Med 2011; 364: 127–135.

    Article  CAS  Google Scholar 

  2. Syvanne M, Castro G, Dengremont C, De Geitere C, Jauhiainen M, Enholm C et al. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I: A-II particles and phospholipid transfer protein. Atherosclerosis 1996; 127: 245–253.

    Article  CAS  Google Scholar 

  3. Cavallero E, Brites F, Delfy B, Nicolaiew N, Decossin C, De Geitere C et al. Abnormal reverse cholesterol transport in controlled type II diabetic patients. Arterioscler Thromb Vasc Biol 1995; 15: 2130–2135.

    Article  CAS  Google Scholar 

  4. Syvanne M, Kahri J, Virtanen KS, Taskinen M-R . HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin dependent diabetes mellitus. Circulation 1995; 92: 364–370.

    Article  CAS  Google Scholar 

  5. Sviridov D, Hoang A, Ooi E, Watts G, Barrett PHR, Nestel P . Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin. Atherosclerosis 2008; 197: 732–739.

    Article  CAS  Google Scholar 

  6. Cuchel M, rader DJ . Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 2006; 113: 2548–2555.

    Article  Google Scholar 

  7. Riemens SC, Van Tol A, Stulp BK, Dullart RPF . Influence of insulin sensitivity and the Taq1B cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. J Lipid Res 1999; 40: 1467–1474.

    CAS  PubMed  Google Scholar 

  8. Chapman MJ, Le Goff W, Guerin M, Kontush A . Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur Heart J 2010; 31: 149–164.

    Article  CAS  Google Scholar 

  9. Yvan-Charvet L, Kling J, Pagler T, Li H, Hubbard B, Fisher T et al. Cholesterol efflux potential and antiinflammtory properties of high-density lipoprotein after treatment with niacin or anacetrapib. Arterioscler Thromb Vasc Biol 2010; 30: 1430–1450.

    Article  CAS  Google Scholar 

  10. Straznicky N, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP et al. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 2010; 59: 1–9.

    Article  Google Scholar 

  11. Grundy SM, Cleeman JI, Daniels SR . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.

    Article  Google Scholar 

  12. Matsuda M, DeFronzo RA . Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999; 22: 1462–1470.

    Article  CAS  Google Scholar 

  13. Straznicky NE, Lambert GW, Masuo K, Eikelis N, Dawood T, Lambert GW et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr 2009; 89: 1–10.

    Article  Google Scholar 

  14. Nestel PJ, Schreibman PH, Ahrens EH . Cholesterol metabolism in human obesity. J Clin Invest 1973; 52: 2389–2397.

    Article  CAS  Google Scholar 

  15. Dullart RPF, Peron F, Sluiter WJ, de Vries R, van Tol A . Plasma lecitihin:cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness. J Clin Endo Metab 2008; 93: 4860–4866.

    Article  Google Scholar 

  16. Bailey D, Ruel I, Hafiane A, Cochrane H, Iatan I, Juahiainen M et al. Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis. J Lipid Res 2010; 51: 785–797.

    Article  CAS  Google Scholar 

  17. Attia N, Fournier N, Vedie B, Cambillau M, Beaune P, Ziegler O et al. Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-B1 and ABCA1-mediated serum cholesterol efflux capacities. Atherosclerosis 2010; 209: 422–429.

    Article  CAS  Google Scholar 

  18. Smith JD . Dysfunctional HDL as a diagnostic and therapeutic target. Arterioscler Thromb Vasc Biol 2010; 30: 151–156.

    Article  CAS  Google Scholar 

  19. van Dam MJ, de Groot E, Clee SM, Hovingh GK, Rodants R, Brooks-Wilson A et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 2002; 359: 37–41.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by Grants-in-Aid from the National Health & Medical Research Council of Australia, and the Heart Foundation of Australia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Nestel.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nestel, P., Hoang, A., Sviridov, D. et al. Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects. Int J Obes 36, 407–413 (2012). https://doi.org/10.1038/ijo.2011.170

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2011.170

Keywords

This article is cited by

Search

Quick links